NFL Biosciences SA (EPA: ALNFL)
France
· Delayed Price · Currency is EUR 1.906
+0.004 (0.21%)
Jan 17, 2025, 5:35 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €18.38 million as of January 17, 2025. Its market cap has increased by 39.45% in one year.
Market Cap
18.38M
Enterprise Value
n/a
Revenue
39.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.91
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 18.38M, a decrease of -5.60%. That is a compound annual growth rate of -1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 18.38M | -3.86% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 122.52B |
| EssilorLuxottica Société anonyme | 111.25B |
| Sartorius Stedim Biotech | 19.17B |
| bioMérieux | 13.05B |
| Ipsen | 10.15B |
| Eurofins Scientific SE | 8.85B |
| Virbac | 2.58B |
| Ramsay Générale de Santé | 1.35B |